Last updated on February 2018

Anticholium Per Se


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Perioperative Period | Toxic Shock Syndrome | Septicemia
  • Age: Between 18 - 85 Years
  • Gender: Male or Female

Inclusion criteria

  • Age 18-85 years
  • APACHE II score <34
  • Intra-abdominal infection
  • findings of diffuse peritonitis or a circumscribed abscess
  • Perioperative sepsis
  • and secure evidence of infection, clinically backed up or secured microbiologically
  • 2 of the following four criteria:
  • fever 38.0 C or hypothermia 36.0 C secured by rectal intravesical or intravascular measurement
  • tachycardia 90/min
  • tachypnea 20/min or hyperventilation secured by arterial blood gas analysis with PaCO2 4.3 kPa or 33 mmHg or mechanical artificial respiration
  • leukocytosis 12,000/mm or leukopenia 4000/mm or 10% immature neutrophils in the differential count
  • Shock (<24 h duration): necessary use of vasopressors despite adequate fluid resuscitation to keep systolic blood pressure 90 mmHg or mean blood pressure 70 mmHg
  • No more than one planned and/or one emergency basis/as an emergency procedure performed since admission (no repeated revisions)
  • No infaust prognosis of a primary or concomitant illness, expecting the death within the follow-up phase
  • No do-not-resuscitate order
  • Written informed consent of full-age patients/their legal guardian to participate [written consent (according to AMG 40 (1) 3b)] and unable to consent adults [ 41 (1) 2 AMG)]

Exclusion criteria

  • Known hypersensitivity to physostigmine salicylate, sodium metabisulfite, sodium EDTA, or any of the other ingredients of Anticholium
  • Known contraindications against Anticholium: gangrene, coronary artery disease
  • Known absolute contraindications against Anticholium: myotonic dystrophy; depolarization block by depolarizing muscle relaxants; intoxication by "irreversibly acting" cholinesterase inhibitors; closed craniocerebral trauma; obstruction in the gastrointestinal tract (mechanical constipation); obstruction in the urinary tract (mechanical urinary retention)
  • Known relative contraindications against Anticholium: bronchial asthma; bradycardia; AV-conduction disturbances
  • Having undergone splenectomy
  • Having undergone solid organ transplantation
  • Positive pregnancy test, pregnancy, and lactation
  • Participation in another clinical trial, according to AMG or the follow-up phase of another study, according to AMG

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.